Search Results - N. Maurea

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Improved Survival and Quality of Life Through an Integrative, Multidisciplinary Oncological Approach: Pathophysiological Analysis of Four Clinical Cancer Cases and Review of the Li... by M. Berretta, M. Berretta, A. Morra, R. Taibi, F. Monari, N. Maurea, M. Ippolito, U. Tirelli, F. Fiorica, L. Montella, G. Facchini, V. Quagliariello, M. Montopoli, M. Montopoli

    Published in Frontiers in Pharmacology (2022-06-01)
    Get full text
    Article


  2. 2

    Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects by S. Cortellino, V. Quagliariello, G. Delfanti, O. Blaževitš, C. Chiodoni, N. Maurea, A. Di Mauro, F. Tatangelo, F. Pisati, A. Shmahala, S. Lazzeri, V. Spagnolo, E. Visco, C. Tripodo, G. Casorati, P. Dellabona, V. D. Longo

    Published in Nature Communications (2023-09-01)
    Get full text
    Article


  3. 3

    Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications i... by V. Quagliariello, M. Passariello, I. Bisceglia, A. Paccone, A. Inno, C. Maurea, R. Rapuano Lembo, L. Manna, M. Iovine, M. L. Canale, M. Scherillo, P. A. Ascierto, D. Gabrielli, C. De Lorenzo, C. De Lorenzo, N. Maurea

    Published in Frontiers in Cardiovascular Medicine (2024-01-01)
    Get full text
    Article


  4. 4

    Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers... by V. Quagliariello, M. L. Canale, I. Bisceglia, M. Iovine, A. Paccone, C. Maurea, M. Scherillo, A. Merola, V. Giordano, G. Palma, A. Luciano, F. Bruzzese, F. Zito Marino, M. Montella, R. Franco, M. Berretta, D. Gabrielli, G. Gallucci, N. Maurea

    Published in Frontiers in Cardiovascular Medicine (2024-05-01)
    Get full text
    Article


  5. 5

    SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzum... by A. Greco, V. Quagliariello, G. Rizzo, A. Tedeschi, S. Schirinzi, A. Turco, M. Galiazzo, M. Acquaro, M. De Amicis, C. Klersy, S. Ghio, L. Perrone, A. Paccone, G. Uccello, M. L. Canale, S. Oliva, F. Guerra, L. De Luca, N. Maurea, L. Scelsi

    Published in Cardio-Oncology (2025-09-01)
    Get full text
    Article


Search Tools: